TrialTargeted oncology2020

Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot Study.

Seonggyu Byeon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.